Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (831-840 of 955) with videos related to

Pageof 96
Sort By:
Clinical Trials (London, England)|January 28, 2022
Effects of patient-reported outcome assessment orderPaul J Novotny, Amylou C Dueck, Daniel Satele, et al.
The Journal of Urology|May 24, 2019
Symptom Based Clustering of Men in the LURN Observational Cohort StudyGang Liu, Victor P Andreev, Margaret E Helmuth, et al.
The Journal of Head Trauma Rehabilitation|May 2, 2015
TBI-QOL: Development and Calibration of Item Banks to Measure Patient Reported Outcomes Following Traumatic Brain InjuryDavid S Tulsky, Pamela A Kisala, David Victorson, et al.
Neurosurgery|January 10, 2014
Advances and innovations in brain arteriovenous malformation surgeryBernard R Bendok, Najib E El Tecle, Tarek Y El Ahmadieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT)Lynne I Wagner, Fengmin Zhao, Fangxin Hong, et al.
Urogynecology (Philadelphia, Pa.)|July 10, 2023
Relationships Between Urinary and Nonurinary Symptoms in Treatment-Seeking Women in LURNAbigail R Smith, Sarah A Mansfield, Catherine S Bradley, et al.
Breast Cancer Research and Treatment|February 19, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)Lynne I Wagner, Fengmin Zhao, Paul E Goss, et al.
Blood Cancer Journal|April 2, 2022
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patientsSamilia Obeng-Gyasi, Noah Graham, Shaji Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinomaRobert J Motzer, Thomas E Hutson, Mark R Olsen, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
Pageof 96

Showing results (831-840 of 955) with videos related to

Sort By:
Pageof 96
Clinical Trials (London, England)|January 28, 2022
Effects of patient-reported outcome assessment orderPaul J Novotny, Amylou C Dueck, Daniel Satele, et al.
The Journal of Urology|May 24, 2019
Symptom Based Clustering of Men in the LURN Observational Cohort StudyGang Liu, Victor P Andreev, Margaret E Helmuth, et al.
The Journal of Head Trauma Rehabilitation|May 2, 2015
TBI-QOL: Development and Calibration of Item Banks to Measure Patient Reported Outcomes Following Traumatic Brain InjuryDavid S Tulsky, Pamela A Kisala, David Victorson, et al.
Neurosurgery|January 10, 2014
Advances and innovations in brain arteriovenous malformation surgeryBernard R Bendok, Najib E El Tecle, Tarek Y El Ahmadieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT)Lynne I Wagner, Fengmin Zhao, Fangxin Hong, et al.
Urogynecology (Philadelphia, Pa.)|July 10, 2023
Relationships Between Urinary and Nonurinary Symptoms in Treatment-Seeking Women in LURNAbigail R Smith, Sarah A Mansfield, Catherine S Bradley, et al.
Breast Cancer Research and Treatment|February 19, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)Lynne I Wagner, Fengmin Zhao, Paul E Goss, et al.
Blood Cancer Journal|April 2, 2022
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patientsSamilia Obeng-Gyasi, Noah Graham, Shaji Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinomaRobert J Motzer, Thomas E Hutson, Mark R Olsen, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
Pageof 96